This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.
Late Submission Abstracts
A late submission abstract refers only to paradigm shifting basic science discovery, or translational or clinical research of relevance to patients. Please note that, due to program schedule considerations, most if not all late submissions will be programmed as posters and scheduled on Saturday, December 14, 2019. This does not mean that there will not be any oral presentatoins selected from late submissions. The deadline for all late submission abstracts and revisions is August 30, 2019.